\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ extra\\-axial\\ mass\\ at\\ the\\ left\\ cp\\ angle\\,\\ hypointense\\ on\\ t1\\,\\ heterogeneous\\ on\\ t2\\ with\\ avid\\ enhancement\\ on\\ the\\ postgadolinium\\ images\\.\\ enhancing\\ mass\\ seen\\ extending\\ into\\ \\(or\\ out\\ of\\)\\ the\\ internal\\ auditory\\ canal\\.\\ \\ focal\\ area\\ of\\ nonenhancement\\ likely\\ represent\\ cystic\\ degeneration\\.\\ \\ positive\\ mass\\ effect\\ on\\ the\\ left\\ aspect\\ of\\ pons\\ and\\ fourth\\ ventricle\\.\ \(0\)\
\-\ vestibular\\ \\(\\'acoustic\\'\\)\\ schwannoma\ \(0\)\
\-\ vestibular\\ schwannoma\ \(8\)\
\-\ unlikely\\ considerations\\ would\\ include\\:\ \(0\)\
\-\ meningioma\\ and\\ epidermoid\ \(0\)\
\-\ patient\\ has\\ sensorineural\\ hearing\\ loss\\,\\ l\\ \\>\\ r\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vestibular\\:\\ 0\\.11272403261007706\ \(0\)\
\-\ schwannoma\\:\\ 0\\.08972100087886084\ \(0\)\
\-\ nonenhancement\\:\\ 0\\.08870007052067112\ \(0\)\
\-\ postgadolinium\\:\\ 0\\.08539338003271962\ \(0\)\
\-\ \\'acoustic\\:\\ 0\\.08539338003271962\ \(0\)\
\-\ cp\\:\\ 0\\.07184562145408001\ \(0\)\
\-\ sensorineural\\:\\ 0\\.0687621273552906\ \(0\)\
\-\ avid\\:\\ 0\\.06387841248212661\ \(0\)\
\-\ considerations\\:\\ 0\\.05659423133167668\ \(0\)\
\-\ pons\\:\\ 0\\.05613439989933531\ \(0\)\
\-\ auditory\\:\\ 0\\.05591120351017322\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.05233147755086417\ \(0\)\
\-\ degeneration\\:\\ 0\\.0498641564308999\ \(0\)\
\-\ \\'\\:\\ 0\\.0498641564308999\ \(0\)\
\-\ hearing\\:\\ 0\\.048394807333085134\ \(0\)\
\-\ fourth\\:\\ 0\\.04751019766485377\ \(0\)\
\-\ unlikely\\:\\ 0\\.04678834822532469\ \(0\)\
\-\ epidermoid\\:\\ 0\\.04678834822532469\ \(0\)\
\-\ hypointense\\:\\ 0\\.04659016654216945\ \(0\)\
\-\ angle\\:\\ 0\\.04610916527854301\ \(0\)\
\-\ l\\:\\ 0\\.044776293082050264\ \(0\)\
\-\ r\\:\\ 0\\.04460970679121617\ \(0\)\
\-\ represent\\:\\ 0\\.04313705047056932\ \(0\)\
\-\ mass\\:\\ 0\\.040981414032674635\ \(0\)\
\-\ canal\\:\\ 0\\.03902279798499094\ \(0\)\
\-\ meningioma\\:\\ 0\\.03777114179833419\ \(0\)\
\-\ ventricle\\:\\ 0\\.03680908411009687\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03611718571028742\ \(0\)\
\-\ would\\:\\ 0\\.034953642280713675\ \(0\)\
\-\ effect\\:\\ 0\\.03477653164447408\ \(0\)\
\-\ on\\:\\ 0\\.033282345396111634\ \(0\)\
\-\ available\\:\\ 0\\.033019759182066635\ \(0\)\
\-\ extending\\:\\ 0\\.033019759182066635\ \(0\)\
\-\ internal\\:\\ 0\\.03292960771699737\ \(0\)\
\-\ \\>\\:\\ 0\\.032634109364006486\ \(0\)\
\-\ out\\:\\ 0\\.03246038938917835\ \(0\)\
\-\ positive\\:\\ 0\\.03187224816418525\ \(0\)\
\-\ t1\\:\\ 0\\.031132132600278663\ \(0\)\
\-\ area\\:\\ 0\\.03105558901303755\ \(0\)\
\-\ aspect\\:\\ 0\\.0308539302814179\ \(0\)\
\-\ enhancing\\:\\ 0\\.03080406359637654\ \(0\)\
\-\ loss\\:\\ 0\\.02851108244216597\ \(0\)\
\-\ cystic\\:\\ 0\\.028329111577606418\ \(0\)\
\-\ focal\\:\\ 0\\.02805165062228048\ \(0\)\
\-\ t2\\:\\ 0\\.02779987090517646\ \(0\)\
\-\ likely\\:\\ 0\\.02770448236707651\ \(0\)\
\-\ include\\:\\ 0\\.027553488368164215\ \(0\)\
\-\ enhancement\\:\\ 0\\.026327457081873975\ \(0\)\
\-\ into\\:\\ 0\\.023371567447812724\ \(0\)\
\-\ left\\:\\ 0\\.02197943147753827\ \(0\)\
\-\ seen\\:\\ 0\\.019409512816870002\ \(0\)\
\-\ images\\:\\ 0\\.01884211370056729\ \(0\)\
\-\ has\\:\\ 0\\.018444827247060664\ \(0\)\
\-\ \\(\\:\\ 0\\.016606016695261162\ \(0\)\
\-\ \\)\\:\\ 0\\.01640316533593805\ \(0\)\
\-\ not\\:\\ 0\\.014193318065999256\ \(0\)\
\-\ at\\:\\ 0\\.013307622446340608\ \(0\)\
\-\ \\:\\:\\ 0\\.012991664551616839\ \(0\)\
\-\ or\\:\\ 0\\.011511755735215028\ \(0\)\
\-\ patient\\:\\ 0\\.009845884263406757\ \(0\)\
\-\ \\,\\:\\ 0\\.009334829845423703\ \(0\)\
\-\ the\\:\\ 0\\.006356288951890841\ \(0\)\
\-\ and\\:\\ 0\\.00413813806280962\ \(0\)\
\-\ of\\:\\ 0\\.004017372441309946\ \(0\)\
\-\ \\.\\:\\ 0\\.0016321625791883344\ \(0\)\
\-\ with\\:\\ 0\\.001344875587240112\ \(0\)\
